Jeffrey Blind v. HHS - Influenza, Guillain Barré syndrome (2026)

Jeffrey Blind filed a petition for compensation under the National Vaccine Injury Compensation Program on December 13, 2024, alleging Guillain Barré syndrome (GBS) resulting from an influenza vaccine received on November 10, 2023. The parties filed a joint stipulation on February 19, 2026, agreeing that Mr.

Blind is entitled to compensation as his GBS is a Table injury. The stipulation noted that the vaccine was administered in the United States, he experienced residual effects for more than six months, and there was no prior award or settlement.

Chief Special Master Corcoran issued a decision on February 20, 2026, awarding Mr. Blind $155,006.41 in compensation for all damages.

Subsequently, on July 9, 2026, Mr. Blind filed a motion for attorney's fees and costs.

Respondent indicated satisfaction with the statutory requirements for the award. On August 17, 2026, Chief Special Master Corcoran granted in part the motion, awarding $37,261.95 in attorney's fees and costs.